Cytek Biosciences, Inc. SEC filings CTKB

Cytek Biosciences, Inc. has 464 filings in SEC EDGAR's recent list, going back to Nov 10, 2020. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.

Cytek Biosciences, Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 4, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 4, 2026 Nov 4, 2026
8-K Current report
Bylaw or fiscal year change
Sep 29, 2026 Sep 23, 2026
8-K Current report
Regulation FD disclosure, Other events
Aug 24, 2026 Aug 21, 2026
10-Q Quarterly report Aug 5, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 5, 2026 Aug 5, 2026
8-K Current report
Officer or director change
Jul 15, 2026 Jul 9, 2026
8-K Current report
Officer or director change
Jun 25, 2026 Jun 18, 2026
8-K Current report
Shareholder vote results
Jun 16, 2026 Jun 10, 2026
8-K Current report
Officer or director change
Jun 2, 2026 May 27, 2026
SD Specialized disclosure (conflict minerals) Jun 1, 2026 —
10-Q Quarterly report May 7, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 7, 2026 May 7, 2026
ARS Annual report to shareholders Apr 28, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 28, 2026 —
DEF 14A Proxy statement Apr 28, 2026 Jun 10, 2026
S-8 Employee stock plan registration Feb 27, 2026 —
10-K Annual report Feb 26, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 26, 2026 Feb 26, 2026
8-K Current report
Results of operations
Jan 13, 2026 Jan 12, 2026
10-Q Quarterly report Nov 5, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 5, 2025 Nov 5, 2025
10-Q Quarterly report Aug 6, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 6, 2025 Aug 6, 2025
8-K Current report
Shareholder vote results
Jun 24, 2025 Jun 18, 2025
SD Specialized disclosure (conflict minerals) May 30, 2025 —
10-Q Quarterly report May 8, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 8, 2025 May 8, 2025
ARS Annual report to shareholders Apr 28, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 28, 2025 —
DEF 14A Proxy statement Apr 28, 2025 Jun 18, 2025
S-8 Employee stock plan registration Feb 28, 2025 —
10-K Annual report Feb 28, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 27, 2025 Feb 27, 2025
8-K Current report
Results of operations
Jan 15, 2025 Jan 15, 2025
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 5, 2024 Nov 5, 2024
8-K Current report
Officer or director change
Sep 12, 2024 Sep 9, 2024
10-Q Quarterly report Aug 6, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 6, 2024 Aug 6, 2024
8-K Current report
Shareholder vote results
Jun 11, 2024 Jun 5, 2024
SD Specialized disclosure (conflict minerals) May 31, 2024 —
10-Q Quarterly report May 8, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 8, 2024 May 8, 2024
ARS Annual report to shareholders Apr 25, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 25, 2024 —
DEF 14A Proxy statement Apr 25, 2024 Jun 5, 2024
8-K Current report
Officer or director change
Mar 19, 2024 Mar 17, 2024
S-8 Employee stock plan registration Mar 14, 2024 —
10-K Annual report Mar 13, 2024 Dec 31, 2023
NT 10-K Filing Mar 1, 2024 Dec 31, 2023
8-K Current report
Results of operations
Mar 1, 2024 Feb 28, 2024
8-K Current report
Officer or director change
Feb 27, 2024 Feb 20, 2024
8-K Current report
Results of operations
Jan 9, 2024 Jan 8, 2024
8-K Current report
Regulation FD disclosure
Nov 28, 2023 Nov 28, 2023
10-Q Quarterly report Nov 14, 2023 Sep 30, 2023
NT 10-Q Filing Nov 13, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 9, 2023 Nov 7, 2023
8-K Current report
Results of operations
Nov 7, 2023 Nov 7, 2023
10-Q Quarterly report Aug 8, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 8, 2023 Aug 8, 2023
8-K Current report
Shareholder vote results
Jun 20, 2023 Jun 14, 2023
8-K/A Amended current report May 15, 2023 Feb 28, 2023
10-Q Quarterly report May 9, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 9, 2023 May 9, 2023
ARS Annual report to shareholders Apr 28, 2023 Dec 31, 2022
DEFA14A Additional proxy material Apr 28, 2023 —
DEF 14A Proxy statement Apr 28, 2023 Jun 14, 2023
S-8 Employee stock plan registration Mar 2, 2023 —
10-K Annual report Mar 1, 2023 Dec 31, 2022
8-K Current report
Results of operations
Feb 28, 2023 Feb 28, 2023
8-K Current report
Acquisition or sale of assets
Feb 28, 2023 Feb 28, 2023
8-K Current report
Material agreement, Regulation FD disclosure
Feb 13, 2023 Feb 13, 2023
10-Q Quarterly report Nov 9, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 9, 2022 Nov 9, 2022
8-K Current report
Officer or director change
Nov 1, 2022 Oct 31, 2022
S-3ASR Automatic shelf registration Aug 26, 2022 —
10-Q Quarterly report Aug 10, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 10, 2022 Aug 10, 2022
8-K Current report
Shareholder vote results
Jun 6, 2022 Jun 1, 2022
10-Q Quarterly report May 12, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 11, 2022 May 11, 2022
DEFA14A Additional proxy material Apr 14, 2022 —
DEF 14A Proxy statement Apr 14, 2022 Jun 1, 2022
S-8 Employee stock plan registration Mar 17, 2022 —
10-K Annual report Mar 17, 2022 Dec 31, 2021
8-K Current report
Officer or director change
Mar 2, 2022 Feb 25, 2022
8-K Current report
Results of operations
Feb 23, 2022 Feb 23, 2022
8-K Current report
Officer or director change
Jan 6, 2022 Dec 31, 2021
10-Q Quarterly report Nov 12, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 8, 2021 Nov 8, 2021
10-Q/A Amended quarterly report Sep 8, 2021 Jun 30, 2021
8-K Current report
Results of operations
Sep 3, 2021 Sep 2, 2021
10-Q Quarterly report Sep 3, 2021 Jun 30, 2021
8-K Current report
Material agreement
Aug 30, 2021 Aug 25, 2021
8-K Current report
Bylaw or fiscal year change, Other events
Jul 27, 2021 Jul 27, 2021
S-8 Employee stock plan registration Jul 23, 2021 —
424B4 Prospectus Jul 23, 2021 —
EFFECT Filing Jul 22, 2021 —
CERT Filing Jul 21, 2021 —
CORRESP Letter to the SEC Jul 20, 2021 —
8-A12B Filing Jul 19, 2021 —
S-1/A Amended registration statement Jul 19, 2021 —
S-1/A Amended registration statement Jul 14, 2021 —
CORRESP Letter to the SEC Jul 13, 2021 —
UPLOAD Letter from the SEC Jul 12, 2021 —
CORRESP Letter to the SEC Jul 2, 2021 —
S-1 Registration statement Jul 2, 2021 —
UPLOAD Letter from the SEC Jun 28, 2021 —
DRSLTR Filing Jun 14, 2021 —
DRS/A Filing Jun 14, 2021 —
UPLOAD Letter from the SEC May 18, 2021 —
DRS Filing Apr 22, 2021 —
D Filing Nov 10, 2020 —

Showing 114 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Laboratory Analytical Instruments (SIC 3826)
Listed as
CTKB (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Fremont, CA
SEC filer status
Accelerated filer
SEC CIK
1831915

Other Laboratory Analytical Instruments companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.